脂肪乳氨基酸(17)葡萄糖

Records for this ingredient, by country (identity only).

ATC B05BA · 1 markets · 25 records

脂肪乳氨基酸(17)葡萄糖 1 markets · 25 records Forms
Filters
MarketCN 25

CN 25 records · 6 shown of 6 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 1,440 mL per mL / per unit basis not statedinjection卡文脂肪乳氨基酸(17)葡萄糖Manufacturer: 四川科伦药业股份有限公司、Manufacturer: 瑞阳制药股份有限公司、Manufacturer: 费森尤斯卡比华瑞制药有限公司、Manufacturer: 辽宁海思科制药有限公司
  • 1,920 mL per mL / per unit basis not statedinjection卡文脂肪乳氨基酸(17)葡萄糖Manufacturer: 四川科伦药业股份有限公司、Manufacturer: 费森尤斯卡比华瑞制药有限公司
  • 1,026 mL per mL / per unit basis not statedinjection卡全脂肪乳氨基酸(17)葡萄糖Manufacturer: 四川科伦药业股份有限公司
  • 900 mL per mL / per unit basis not statedinjectionManufacturer: 费森尤斯卡比华瑞制药有限公司 ×6Manufacturer: 辽宁海思科制药有限公司
  • 2,053 mL per mL / per unit basis not statedinjectionManufacturer: 四川科伦药业股份有限公司 ×7
  • 1,540 mL per mL / per unit basis not statedinjectionManufacturer: 四川科伦药业股份有限公司 ×7

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.